Australia markets closed

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
16.57+0.70 (+4.41%)
At close: 04:00PM EDT
16.27 -0.30 (-1.81%)
After hours: 07:39PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
137,636
298,395
171,445
130,237
-
Other short-term investments
-
0
19,821
10,041
5,007
Total cash
137,636
298,395
191,266
140,278
-
Net receivables
53,514
10,439
6,619
5,987
-
Inventory
15,644
6,805
7,870
4,651
-
Other current assets
138
354
432
883
-
Total current assets
219,329
320,806
210,106
159,244
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
4,426
4,023
4,251
470
-
Accumulated depreciation
-723
-406
-275
-340
-
Net property, plant and equipment
3,703
3,617
3,976
130
-
Equity and other investments
16,489
0
-
-
0
Intangible assets
194,049
32,471
-
-
-
Total non-current assets
250,785
54,824
27,682
33,110
-
Total assets
470,114
375,630
237,788
192,354
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
14,795
3,975
2,768
4,256
-
Taxes payable
729
8,702
79
0
-
Accrued liabilities
38,282
26,077
19,630
14,374
-
Other current liabilities
465
238
243
106
-
Total current liabilities
76,063
57,588
27,063
22,756
-
Non-current liabilities
Other long-term liabilities
485
14,064
-
-
-
Total non-current liabilities
6,170
17,621
3,894
0
-
Total liabilities
82,233
75,209
30,957
22,756
-
Stockholders' equity
Common stock
107
105
103
104
-
Retained earnings
121,272
49,862
-26,310
-53,705
-
Accumulated other comprehensive income
14
24
-148
31
-
Total stockholders' equity
387,881
300,421
206,831
169,598
-
Total liabilities and stockholders' equity
470,114
375,630
237,788
192,354
-